Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion type Assertion NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_head.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion evidence source_evidence_literature NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion SIO_000772 23441129 NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion wasDerivedFrom befree-2016 NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion wasGeneratedBy ECO_0000203 NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.